A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2002
12/12/2002	CA2438099A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/12/2002	CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	CA2412652A1 Remedies for allergic diseases and process for producing the same
12/11/2002	WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum
12/11/2002	WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264600A1 Immune enhancement compositions and use thereof
12/11/2002	EP1264598A1 Altering an immune response by influencing the interaction of LAIR with its ligand
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263968A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/11/2002	EP1263965A2 Avirulent, immunogenic flavivirus chimeras
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263785A2 Mutated il-13 molecules and their uses
12/11/2002	EP1263779A1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/11/2002	EP1263775A1 Hla binding peptides and their uses
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263468A1 Formulation solubilizing water-insoluble agents and preparation method thereof
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263457A2 Hiv immune adjuvant therapy
12/11/2002	EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
12/11/2002	EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
12/11/2002	EP0894001B1 Inhibitor of immunoglobulin e antibody production for the treatment of type i allergy-related diseases
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
12/11/2002	CN1384884A Herpes virus vectors for dendritic cells
12/11/2002	CN1384883A Production of recombinant respiratory syncytical viruses expressing immune modulatory molecules
12/11/2002	CN1384878A IREN protein, its preparation and use
12/11/2002	CN1384840A Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
12/11/2002	CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist
12/11/2002	CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents
12/11/2002	CN1384758A Mutant human CD80 and copositions for and methods of making and using the same
12/11/2002	CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors
12/11/2002	CN1384740A Delayed-action form of administration containing tramadol saccharinate
12/11/2002	CN1384739A Oral pharmaceutical forms of administration with a delayed action
12/11/2002	CN1384735A Oral dosage forms
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors
12/11/2002	CN1383825A Flunarizine hydrochloride injection and its prepn process
12/11/2002	CN1383816A External Tranilast lipid gel prepn and its prepn process
12/11/2002	CN1095836C Benzimidazole derivative
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CN1095834C Quinolinone derivatives and antianaphylactic agent containing said quinolinone derivative as biological active component
12/11/2002	CN1095676C Health food capable of lowering blood lipoid, resisting senility and regulating immunity
12/11/2002	CN1095673C New application of medicine containing ginsenoside Rhl
12/11/2002	CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum
12/11/2002	CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/10/2002	US6492552 Disulfide derivatives useful for treating allergic diseases
12/10/2002	US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents
12/10/2002	US6492507 Polynucleotides encoding human eosinophil-derived basic protein
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492425 Inhibitors of transcription factor-NF-κB
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492418 Administering benzamide-disulfide derivative for therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lung and manifestations of systemic mastocytosis
12/10/2002	US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase

1 ... 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 ... 1172